medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2020, Number S1

<< Back Next >>

Rev Latin Infect Pediatr 2020; 33 (S1)

Etiology and pathophysiology of SARS-CoV-2

Alvarado AI, Bandera AJ, Carreto BLE, Pavón RGF, Alejandre GA

Language: Spanish
References: 19
Page: 5-9
PDF size: 212.02 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Ye ZW, Yuan S, Yuen KS, Fung SY, Chan CP, Jin DY. Zoonotic origins of human coronaviruses. Int J Biol Sci. 2020; 16 (10): 1686-1697.

  2. Chan JFW, Lau SKP, To KKW, Cheng VCC, Woo PCY, Yue KY. Middle east respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev. 2015; 28 (2): 465-522.

  3. Shanmugaraj B, Siriwattananon K, Wangkanont K, Phoolcharoen W. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). Asian Pac J Allergy Immunol. 2020; 38 (1): 10-18.

  4. Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 2016; 24 (6): 490-502.

  5. Weiss SR, Navas-Martin S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev [Internet]. 2005; 69 (4): 635-664. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1306801/pdf/0007-05.pdf

  6. Qiang XL, Xu P, Fang G, Liu W Bin, Kou Z. Using the spike protein feature to predict infection risk and monitor the evolutionary dynamic of coronavirus. Infect Dis poverty. 2020; 9 (1): 33.

  7. Calvo C, García López-Hortelano M, de Carlos Vicente JC, Vázquez Martínez JL; Grupo de trabajo de la Asociación Española de Pediatría para el brote de infección por Coronavirus, colaboradores con el Ministerio de Sanidad; Miembros del Grupo de Expertos de la AEP. Recomendaciones sobre el manejo clínico de la infección por el «nuevo coronavirus» SARS-CoV2. Grupo de trabajo de la Asociación Española de Pediatría (AEP). An Pediatr (Barc). 2020; 92 (4): 241.e1-241.e11.

  8. Enjuanes L, Smerdou C, Castilla J, Anton IM, Torres JM, Sola I et al. Development of protection against coronavirus induced diseases: a review. Adv Exp Med Biol. 1995; 380: 197-211.

  9. Masters PS, Kuo L, Ye R, Hurst KR, Koetzner CA, Hsue B. Genetic and molecular biological analysis of protein-protein interactions in coronavirus assembly. Adv Exp Med Biol. 2006; 581: 163-173.

  10. Siu YL, Teoh KT, Lo J, Chan CM, Kien F, Escriou N et al. The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles. J Virol. 2008; 82 (22): 11318-11330.

  11. Li X, Zai J, Zhao Q, Nie Q, Li Y, Foley BT et al. Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2. J Med Virol. 2020; 92 (6): 602-611.

  12. Lai CC, Liu YH, Wang CY, Wang YH, Hsueh SC, Yen MY et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths. J Microbiol Immunol Infect. 2020; 53 (3): 404-412. doi: 10.1016/j.jmii.2020.02.012

  13. Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W et al. Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses [Internet]. Viruses. 2020; 12 (4): 372. Available from: https://www.mdpi.com/1999-4915/12/4/372

  14. Alyami M. Guidance for Corona Virus Disease 2019 [Internet]. 2020. 4-5, 42-43 p. Available from: https://www.uoa.gr/fileadmin/user_upload/PDF-files/anakoinwseis/themata_ygeias/1603_Guidance_for_Corona_Virus_Disease_2019.pdf

  15. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res [Internet]. 2020; 7 (1): 11. Available from: https://mmrjournal.biomedcentral.com/track/pdf/10.1186/s40779-020-00240-0

  16. Shi Y, Wang Y, Shao C, Huang J, Gan J, Huang X et al. COVID-19 infection: the perspectives on immune responses. Cell Death Differ [Internet]. 2020; 27 (5): 1451-1454. Available from: http://dx.doi.org/10.1038/s41418-020-0530-3

  17. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med [Internet]. 2020; 382 (18): 1708-1720. Available from: https://www.nejm.org/doi/pdf/10.1056/nejmoa2002032

  18. Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol [Internet]. 2020; 20 (5): 269-270. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32273594

  19. Nikolich-Zugich J, Knox KS, Rios CT, Natt B, Bhattacharya D, Fain MJ. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience [Internet]. 2020; 42 (2): 505-514. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32274617




2020     |     www.medigraphic.com